Jun Wei

19PUBLICATIONS
121CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jun 08, 2026
Combination of Selpercatinib and Trametinib Overcomes Resistance to RET Inhibitors in RET-Mutant Medullary Thyroid Carcinoma.

|Jul 23, 2024
CAR T-cells targeting FGFR4 and CD276 simultaneously show potent antitumor effect against childhood rhabdomyosarcoma.

Meijie Tian, Jun S Wei, Adam Tai-Chi Cheuk

|Feb 24, 2024
KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcoma.

Yong Yean Kim, Berkley E Gryder, Ranuka Sinniah

|Sep 21, 2023
Piperacetazine Directly Binds to the PAX3::FOXO1 Fusion Protein and Inhibits Its Transcriptional Activity.

Kay Nakazawa, Taryn Shaw, Young K Song

|Aug 26, 2023
Preclinical Evaluation of the FGFR-Family Inhibitor Futibatinib for Pediatric Rhabdomyosarcoma.

Jerry T Wu, Adam Cheuk, Kristine Isanogle

|Jan 06, 2023
A stem cell epigenome is associated with primary nonresponse to CD19 CAR T cells in pediatric acute lymphoblastic leukemia.

Katherine E Masih, Rebecca A Gardner, Hsien-Chao Chou

Pageof 4

Frequent Collaborators

14 joint publications

Javed Khan

8 joint publications

Hsien-Chao Chou

6 joint publications

David Milewski

5 joint publications

Xinyu Wen